HAP Trading’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

HAP Trading’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-31,733	Closed	-$601K	–	1237
2017 Q4	$601K	Buy	+31,733	New	+$575K	0.03%	362

Other funds holding SPPI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NYLIM

New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAP Trading's SPPI Position: Q1 2018 in Review

HAP Trading sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2018, closing a stake of 31,733 shares — an estimated $601K sold.

HAP Trading first reported a position in SPPI in Q4 2017 and held it in 1 quarter. The position peaked at $601K in Q4 2017. 161 funds tracked by Wall St. Rank hold SPPI as of Q1 2018.

HAP Trading reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2018 after selling out during the quarter.
HAP Trading sold 31,733 Spectrum Pharmaceuticals Inc shares in Q1 2018, an estimated $601K.
HAP Trading first reported a position in Spectrum Pharmaceuticals Inc in Q4 2017 and held it in 1 quarter.
HAP Trading's Spectrum Pharmaceuticals Inc position peaked at $601K in Q4 2017.
161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2018.

Based on HAP Trading's 13F filing for Q1 2018, filed 11 May 2018.